Identification and purification of two distinct complexes containing the five RAD51 paralogs

  1. Jean-Yves Masson1,
  2. Madalena C. Tarsounas1,
  3. Alicja Z. Stasiak2,
  4. Andrzej Stasiak2,
  5. Rajvee Shah1,
  6. Michael J. McIlwraith1,
  7. Fiona E. Benson3, and
  8. Stephen C. West1,4
  1. 1Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, UK; 2Laboratoire d'Analyse Structurale, Université de Lausanne, 1015 Lausanne, Switzerland; 3Lancaster University, Department of Biological Sciences, Institute of Environmental and Natural Sciences, Lancaster LA1 4YQ, UK

Abstract

Cells defective in any of the RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) are sensitive to DNA cross-linking agents and to ionizing radiation. Because the paralogs are required for the assembly of DNA damage-induced RAD51 foci, and mutant cell lines are defective in homologous recombination and show genomic instability, their defect is thought to be caused by an inability to promote efficient recombinational repair. Here, we show that the five paralogs exist in two distinct complexes in human cells: one contains RAD51B, RAD51C, RAD51D, and XRCC2 (defined as BCDX2), whereas the other consists of RAD51C with XRCC3. Both protein complexes have been purified to homogeneity and their biochemical properties investigated. BCDX2 binds single-stranded DNA and single-stranded gaps in duplex DNA, in accord with the proposal that the paralogs play an early (pre-RAD51) role in recombinational repair. Moreover, BCDX2 complex binds specifically to nicks in duplex DNA. We suggest that the extreme sensitivity of paralog-defective cell lines to cross-linking agents is owing to defects in the processing of incised cross links and the consequential failure to initiate recombinational repair at these sites.

Keywords

Footnotes

  • 4 Corresponding author.

  • E-MAIL s.west{at}icrf.icnet.uk; FAX 44-20-7269-3811.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.947001.

    • Received September 24, 2001.
    • Accepted October 31, 2001.
| Table of Contents

Life Science Alliance